These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36078513)

  • 41. Simulated daily plan adaptation for magnetic resonance-guided liver stereotactic body radiotherapy.
    Taylor E; Lukovic J; Velec M; Shessel A; Stanescu T; Dawson L; Létourneau D; Lindsay P
    Acta Oncol; 2021 Feb; 60(2):260-266. PubMed ID: 33170058
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Traceable reference dosimetry in MRI guided radiotherapy using alanine: calibration and magnetic field correction factors of ionisation chambers.
    Billas I; Bouchard H; Oelfke U; Duane S
    Phys Med Biol; 2021 Aug; 66(16):. PubMed ID: 34049290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Magnetic Resonance Imaging-Guided Adaptive Radiation Therapy: A "Game Changer" for Prostate Treatment?
    Pathmanathan AU; van As NJ; Kerkmeijer LGW; Christodouleas J; Lawton CAF; Vesprini D; van der Heide UA; Frank SJ; Nill S; Oelfke U; van Herk M; Li XA; Mittauer K; Ritter M; Choudhury A; Tree AC
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):361-373. PubMed ID: 29353654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
    Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
    Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variability of Gross Tumor Volume Delineation for Stereotactic Body Radiotherapy of the Lung With Tri-
    Wee CW; An HJ; Kang HC; Kim HJ; Wu HG
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818787383. PubMed ID: 30012039
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current Status of Anatomical Magnetic Resonance Imaging in Brachytherapy and External Beam Radiotherapy Planning and Delivery.
    Ingle M; Lalondrelle S
    Clin Oncol (R Coll Radiol); 2020 Dec; 32(12):817-827. PubMed ID: 33169690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Time-Driven Activity-Based Costing Comparison of CT-Guided Versus MR-Guided SBRT.
    Parikh NR; Lee PP; Raman SS; Cao M; Lamb J; Tyran M; Chin W; Gilchrist T; Agazaryan N; Mittauer K; Steinberg ML; Raldow AC
    JCO Oncol Pract; 2020 Nov; 16(11):e1378-e1385. PubMed ID: 32539652
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology.
    Hall WA; Kishan AU; Hall E; Nagar H; Vesprini D; Paulson E; Van der Heide UA; Lawton CAF; Kerkmeijer LGW; Tree AC
    Front Oncol; 2022; 12():962897. PubMed ID: 36132128
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MR-safe personal radiation dosimeters.
    Tchistiakova E; Kim A; Song WY; Pang G
    J Appl Clin Med Phys; 2017 Jul; 18(4):180-184. PubMed ID: 28585406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A microcost analysis of radiation therapy of localized prostate cancer].
    Zemplényi AT; Mangel L; Kaló Z; Endrei D; Boncz I
    Orv Hetil; 2016 Mar; 157(12):461-8. PubMed ID: 26971646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
    Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
    J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Cost-Utility Analysis of Magnetic Resonance (MR) Guided Brachytherapy Versus Two-Dimensional and Computed Tomography (CT) Guided Brachytherapy for Locally Advanced Cervical Cancer.
    Perdrizet J; D'Souza D; Skliarenko J; Ang M; Barbera L; Gutierrez E; Ravi A; Tanderup K; Warde P; Chan K; Isaranuwatchai W; Milosevic M
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):512-521. PubMed ID: 32169410
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Online Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications.
    Acharya S; Fischer-Valuck BW; Kashani R; Parikh P; Yang D; Zhao T; Green O; Wooten O; Li HH; Hu Y; Rodriguez V; Olsen L; Robinson C; Michalski J; Mutic S; Olsen J
    Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):394-403. PubMed ID: 26678659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.
    Westwood M; Joore M; Grutters J; Redekop K; Armstrong N; Lee K; Gloy V; Raatz H; Misso K; Severens J; Kleijnen J
    Health Technol Assess; 2013 Apr; 17(16):1-243. PubMed ID: 23611316
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MRI-guided prostate adaptive radiotherapy - A systematic review.
    McPartlin AJ; Li XA; Kershaw LE; Heide U; Kerkmeijer L; Lawton C; Mahmood U; Pos F; van As N; van Herk M; Vesprini D; van der Voort van Zyp J; Tree A; Choudhury A;
    Radiother Oncol; 2016 Jun; 119(3):371-80. PubMed ID: 27162159
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of hydrogel peri-rectal spacer insertion on prostate gland intra-fraction motion during 1.5 T MR-guided stereotactic body radiotherapy.
    Cuccia F; Mazzola R; Nicosia L; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Vitale C; Mantoan B; De Simone A; Sicignano G; Ruggieri R; Cavalleri S; Alongi F
    Radiat Oncol; 2020 Jul; 15(1):178. PubMed ID: 32698843
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Advances in magnetic resonance imaging guided radiation therapy].
    Xu W; Wang C; Ma Y; Fang C; Gong H; Zhang G; Qu B; Xu S
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2021 Feb; 38(1):161-168. PubMed ID: 33899441
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Potential Value of MRI in External-Beam Radiotherapy for Cervical Cancer.
    Cree A; Livsey J; Barraclough L; Dubec M; Hambrock T; Van Herk M; Choudhury A; McWilliam A
    Clin Oncol (R Coll Radiol); 2018 Nov; 30(11):737-750. PubMed ID: 30209010
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dose evaluation of fast synthetic-CT generation using a generative adversarial network for general pelvis MR-only radiotherapy.
    Maspero M; Savenije MHF; Dinkla AM; Seevinck PR; Intven MPW; Jurgenliemk-Schulz IM; Kerkmeijer LGW; van den Berg CAT
    Phys Med Biol; 2018 Sep; 63(18):185001. PubMed ID: 30109989
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current practices and perspectives on the integration of contrast agents in MRI-guided radiation therapy clinical practice: A worldwide survey.
    Boldrini L; Alongi F; Romano A; Charles Davies D; Bassetti M; Chiloiro G; Corradini S; Gambacorta MA; Placidi L; Tree AC; Westley R; Nicosia L
    Clin Transl Radiat Oncol; 2023 May; 40():100615. PubMed ID: 36968577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.